Compound Summary
L-Theanine
Compound Information
L-Theanine
Compound Name: | L-Theanine |
Compound CID: | 439378 |
Synonyms: | L-Theanine 3081-61-6 Theanine Theanin N-Ethyl-L-glutamine More... |
Iupac Name: | (2S)-2-amino-5-(ethylamino)-5-oxopentanoic acid |
InChI: | InChI=1S/C7H14N2O3/c1-2-9-6(10)4-3-5(8)7(11)12/h5H,2-4,8H2,1H3,(H,9,10)(H,11,12)/t5-/m0/s1 |
InChIKey: | DATAGRPVKZEWHA-YFKPBYRVSA-N |
Canonical Smiles: | CCNC(=O)CCC(C(=O)O)N |
Isomeric Smiles: | CCNC(=O)CC[C@@H](C(=O)O)N |
Molecular Weight: | 174.2 |
Molecular Formula: | C7H14N2O3 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
L-Theanine
Molecular Weight: | 174.2 |
Molecular Formula: | C7H14N2O3 |
Hydrogen Bond Donor Count: | 3 |
Hydrogen Bond Acceptor Count: | 4 |
Rotatable Bond Count: | 5 |
Heavy Atom Count: | 12 |
Complexity: | 170 |
Synonyms
L-Theanine
| L-Theanine | L-Theanine |
|---|---|
L-Theanine |
3081-61-6 |
Theanine |
Theanin |
N-Ethyl-L-glutamine |
Suntheanine |
(S)-2-Amino-5-(ethylamino)-5-oxopentanoic acid |
N5-Ethyl-L-glutamine |
L-gamma-Glutamylethylamide |
N(5)-ethyl-L-glutamine |
N-gamma-Ethyl-L-glutamine |
UNII-8021PR16QO |
(2S)-2-amino-5-(ethylamino)-5-oxopentanoic acid |
CHEBI:17394 |
L-Glutamic acid ?-(ethylamide) |
8021PR16QO |
CCRIS 7326 |
EINECS 221-379-0 |
NSC 21308 |
n-ethylglutamine |
L-Theamine |
MFCD00059653 |
NSC-21308 |
HSDB 8166 |
(+)-Theanine |
N?-Ethyl-L-glutamine |
H-Glu(NHEt)-OH |
N-?-Ethyl-L-glutamine |
Spectrum2_001693 |
Spectrum3_001137 |
Spectrum4_001984 |
Spectrum5_000897 |
Glutamine, N-gamma-ethyl- |
Glutamine, N-ethyl-, L- |
BSPBio_002633 |
KBioGR_002514 |
SCHEMBL190716 |
SPECTRUM1505254 |
SPBio_001646 |
EBD678 |
CHEMBL3039113 |
KBio3_002133 |
DTXSID80184817 |
L-glutamic acid -r-monoethylamide |
L-Theanine, >=98% (HPLC) |
BCP28252 |
ZINC1532828 |
CCG-38778 |
CT0238 |
s3852 |
AKOS016842508 |
AM82649 |
DB12444 |
L-Theanine (Ngamma-ethyl-L-glutamine) |
SDCCGMLS-0066811.P001 |
NCGC00178565-01 |
AC-23939 |
AS-12265 |
HY-15121 |
AB0006097 |
CS-0003777 |
N2085 |
T0954 |
C01047 |
081T616 |
A820634 |
Q909931 |
SR-05000002409 |
Q-201330 |
SR-05000002409-1 |
(2S)-2-azanyl-5-(ethylamino)-5-oxidanylidene-pentanoic acid |
C6B5A580-D410-4464-ADB8-543860137D4C |
L-Theanine, United States Pharmacopeia (USP) Reference Standard |
Experimental Data
L-Theanine
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 0.100000000000000 | umol/L | 22.100000000000000 | 22.900000000000000 | 0.040000000000000 | 24.900000000000000 | 26.000000000000000 | 0.040000000000000 | S | N2 | 22422488 | Active | |
| Caenorhabditis elegans | 10.000000000000000 | umol/L | 22.100000000000000 | 22.600000000000000 | 0.020000000000000 | 24.900000000000000 | 25.500000000000000 | 0.020000000000000 | S | N2 | 22422488 | Active | |
| Caenorhabditis elegans | 1.000000000000000 | umol/L | 22.100000000000000 | 22.800000000000000 | 0.030000000000000 | 24.900000000000000 | 25.500000000000000 | 0.020000000000000 | S | N2 | 22422488 | Active | |
| Caenorhabditis elegans | 10.000000000000000 | mM | -15.000000000000000 | S | N2 | 25643626 | Inactive | ||||||
| Caenorhabditis elegans | 0.100000000000000 | mM | 14.000000000000000 | S | N2 | 25643626 | Active | ||||||
| Caenorhabditis elegans | 1.000000000000000 | mM | 8.000000000000000 | S | N2 | 25643626 | Active | ||||||
| Caenorhabditis elegans | 5.000000000000000 | mM | 10.000000000000000 | S | N2 | 25643626 | Active |
Experimental Data Visualization
L-Theanine
Statistics Data
L-Theanine
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 14.000000000000000 | 0.040000000000000 | 2 | 7 |
Statistics Data Visualization
L-Theanine
